Recipients should expect to be enrolled in the FREEDOM-1 and FREEDOM-2 trials for about five years and up to one year for donors.

For more information on finding a donor for potential recipients in FREEDOM-1, please visit National Kidney Foundation's Living Donations page.

The investigational cell therapy is administered as a one-time infusion. If you would like more information, please email medicalinformation@talaristx.com

Studies are currently in progress. In a phase 2 study of FCR001 in living donor kidney transplants, 70% of participants were able to stop taking immunosuppressive medicines one year after their transplant. Participants are still being monitored for long-term safety. For more information, visit our solid organ transplantation page.

By contributing to this research, participants have the opportunity to help advance the future of living donor kidney transplants. The study team will discuss all potential trial-related benefits and risks with participants before they decide to take part.

It is important to note that participants may experience side effects and/or health complications from the medicines, investigational cell therapy, and/or assessments and procedures. The study team will discuss all potential trial-related benefits and risks with participants before they decide to take part. All side effects and/or health complications should be immediately reported to the study team so they can monitor participant health and safety.

Study-related costs for recipients and donor participants may be covered. Study participants may still be responsible for any co-pays associated with visits. The study sponsor will cover the cost of immunosuppressive medicines, if needed, for up to five years following the stem cell transplant.

‍

Recipients and donors (plus their potential companions) may be reimbursed for travel (airfare, mileage, or other forms of public transportation), hotel/lodging, and meal expenses. There are limits to how much can be reimbursed. The study team will discuss all options with you.

‍

Download these files for more information on reimbursement.

Yes. As with all clinical trials, participation is voluntary, and participants are free to leave these trials at any time and for any reason. Those who decide not to take part will not be penalized or lose any benefits to which they are entitled. Participants will also remain under your care for all non-study–related needs.